thyroxine has been researched along with Apolipoprotein B-100, Familial Defective in 13 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Excerpt | Relevance | Reference |
---|---|---|
" With initial values below 350 mg/100 ml the difference in the cholesterol decrease between the two dosage groups is not therapeutically relevant." | 6.65 | [Therapy of hyperlipoproteinemia type IIa and IIb with etiroxate-HCl. Dose-response comparison]. ( Banz, H; Gall, FP, 1979) |
"Six female patients with a primary hyperlipoproteinemia type IIa received 40 mg/day etiroxate for 2 months." | 3.66 | Effects of etiroxate on low density and high density lipoproteins in hypercholesterolemic patients. ( Schwandt, P; Weisweiler, P, 1981) |
" With initial values below 350 mg/100 ml the difference in the cholesterol decrease between the two dosage groups is not therapeutically relevant." | 2.65 | [Therapy of hyperlipoproteinemia type IIa and IIb with etiroxate-HCl. Dose-response comparison]. ( Banz, H; Gall, FP, 1979) |
"The surgical treatment of hypercholesterolemia and the treatment of homozygous and other forms of hypercholesterolemia are also detailed." | 2.36 | Treatment of hypercholesterolemia. ( Kane, JP; Malloy, MJ, 1982) |
" The high circulating levels of D-T4 and possibly of D-T3 after chronic administration of D-T4 may be responsible for the saturation of pituitary nuclear T3 receptors, resulting in the suppression of the TRH-induced TSH response." | 1.26 | Effects of dextrothyroxine on the pituitary-thyroid axis in hypercholesterolemic children and goitrous adults. ( Brun, LD; Coulombe, P; Dussault, JH; Gagné, C; Lupien, PJ; Moorjani, S, 1980) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (76.92) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Paja Fano, M | 1 |
Egaña Zunzunegui, N | 1 |
Lizarraga Zufiaurre, A | 1 |
Elorza Olabegoya, R | 1 |
Rivero, M | 1 |
Otermin, I | 1 |
Pereda, A | 1 |
Cía, M | 1 |
Martínez, M | 1 |
Thompson, GR | 1 |
Soutar, AK | 1 |
Spengel, FA | 1 |
Jadhav, A | 1 |
Gavigan, SJ | 1 |
Myant, NB | 1 |
Kolodin, VA | 1 |
Gasilin, VS | 1 |
Baranov, VA | 1 |
Antonov, IuS | 1 |
Dokuchaeva, EA | 1 |
Brun, LD | 1 |
Gagné, C | 1 |
Coulombe, P | 1 |
Lupien, PJ | 1 |
Dussault, JH | 1 |
Moorjani, S | 1 |
Kane, JP | 1 |
Malloy, MJ | 1 |
Zadák, Z | 1 |
Kalinová, M | 1 |
Sobotka, L | 1 |
Weisweiler, P | 1 |
Schwandt, P | 1 |
Banz, H | 2 |
Gall, FP | 2 |
Kuklinski, B | 1 |
Titlbach, O | 1 |
Kellner, K | 1 |
Benvenga, S | 1 |
Robbins, J | 1 |
Nakao, S | 1 |
Ueda, M | 1 |
Yamashita, S | 1 |
Matsuzawa, Y | 1 |
Harada, M | 1 |
Matsuda, T | 1 |
1 review available for thyroxine and Apolipoprotein B-100, Familial Defective
Article | Year |
---|---|
Treatment of hypercholesterolemia.
Topics: Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Heterozygote; Homozygote; Humans; Hyper | 1982 |
2 trials available for thyroxine and Apolipoprotein B-100, Familial Defective
Article | Year |
---|---|
[Dose-response comparison with etiroxat HCl in hyperlipoproteinemias types IIa and IIb].
Topics: Anticholesteremic Agents; Dose-Response Relationship, Drug; Female; Humans; Hyperlipoproteinemia Typ | 1980 |
[Therapy of hyperlipoproteinemia type IIa and IIb with etiroxate-HCl. Dose-response comparison].
Topics: Cholesterol; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Hyperlipoproteinemia | 1979 |
10 other studies available for thyroxine and Apolipoprotein B-100, Familial Defective
Article | Year |
---|---|
[Isolated adult thyrotropin deficiency. An unusual finding of unknown etiology].
Topics: Adenoma; Adult; Age of Onset; Asthenia; Congenital Hypothyroidism; Humans; Hyperlipoproteinemia Type | 2010 |
[Musculoskeletal adverse effects of levofloxacin].
Topics: Anti-Bacterial Agents; Arthralgia; Arthritis; Arthritis, Infectious; Arthroplasty, Replacement, Knee | 2006 |
Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo.
Topics: Biological Transport; Homozygote; Humans; Hyperlipoproteinemia Type II; Hypothyroidism; Lipoproteins | 1981 |
[Role of excessive body weight and hormonal changes in the development of the main types of hyperlipoproteinemia].
Topics: Adrenocortical Hyperfunction; Adult; Growth Hormone; Humans; Hydrocortisone; Hyperinsulinism; Hyperl | 1984 |
Effects of dextrothyroxine on the pituitary-thyroid axis in hypercholesterolemic children and goitrous adults.
Topics: Adult; Animals; Child; Dextrothyroxine; Female; Goiter; Humans; Hyperlipoproteinemia Type II; Male; | 1980 |
[Etiroxate treatment for hyperlipoproteinaemia type IIa and IIb (author's transl)].
Topics: Adult; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Thyroxine | 1982 |
Effects of etiroxate on low density and high density lipoproteins in hypercholesterolemic patients.
Topics: Adult; Apolipoproteins; Cholesterol; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins, HDL | 1981 |
[Modification of thyroid hormones by unsaturated fatty acid after noradrenaline load].
Topics: Adult; Dietary Fats; Fatty Acids, Unsaturated; Helianthus; Humans; Hyperlipoproteinemia Type II; Mal | 1980 |
Enhancement of thyroxine entry into low density lipoprotein (LDL) receptor-competent fibroblasts by LDL: an additional mode of entry of thyroxine into cells.
Topics: Cell Line; Fibroblasts; Humans; Hyperlipoproteinemia Type II; Kinetics; Lipoproteins, LDL; Prealbumi | 1990 |
[A case of familial hypercholesterolemia associated with Basedow's disease].
Topics: Adult; Graves Disease; Humans; Hyperlipoproteinemia Type II; Male; Probucol; Thyroxine; Triiodothyro | 1987 |